Caesarean section

Series
Obstetrics and gynecology
Status
Published
Date
Number of report
080

Ask the expert

(we accept only company emails)

The report presents a summary of the reimbursement situation for elective and emergency Caesarean section for maternal and fetal indications in Europe.

Both “classical” and lower uterine segment Caesarean section will be considered under the scope.

The only reimbursement within public / statutory health insurance systems is analyzed.

The report includes essential information about reimbursement and national funding, including:

  • A brief overview of the reimbursement system for medical devices
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions in indications or scenarios for the use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Denmark
  • England (UK)
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Sweden
  • Switzerland

It is also possible to add analysis in Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Manufacturers of devices for caesarean section:

  • A. Schweickhardt
  • Aesculap USA
  • Aspen Surgical
  • Avante
  • Benelux Surgical
  • Clinical Innovations (Omni-C)
  • Cooper Surgical (Mityvac, MityOne, Mystic II)
  • DEWIMED Smart Innovation
  • Dixion Vertrieb medizinischer Geräte
  • DTR Medical
  • Haemonetics (Cell Saver Elite+, Cell Saver 5+, Cell Saver Elite, SmartSuction Harmony)
  • Johnson & Johnson
  • MedGyn
  • Medtronic (autoLog, HMS Plus)
  • Schweickhardt
  • Terumo (CATS, CATSmart)

Table of content is not available at the moment. Report is still ongoing.

10

Sep 2019

The report presents a summary of the reimbursement situation for caesarean section in Europe. Both “classical” and lower uterine segment Caesarean section are considered under the scope. The only reimbursement within public / statutory health insurance systems is analyzed. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland. It is also possible to add analysis in the Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Read more
(we accept only company emails)